These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 10982197

  • 1. Is melatonin treatment effective for tardive dyskinesia?
    Shamir E, Barak Y, Plopsky I, Zisapel N, Elizur A, Weizman A.
    J Clin Psychiatry; 2000 Aug; 61(8):556-8. PubMed ID: 10982197
    [Abstract] [Full Text] [Related]

  • 2. Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study.
    Shamir E, Barak Y, Shalman I, Laudon M, Zisapel N, Tarrasch R, Elizur A, Weizman R.
    Arch Gen Psychiatry; 2001 Nov; 58(11):1049-52. PubMed ID: 11695951
    [Abstract] [Full Text] [Related]

  • 3. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM, Yu SC, Lin CC.
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H, Geraisy N, Schwartz M.
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study.
    Libov I, Miodownik C, Bersudsky Y, Dwolatzky T, Lerner V.
    J Clin Psychiatry; 2007 Jul; 68(7):1031-7. PubMed ID: 17685739
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vitamin B(6) in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study.
    Lerner V, Miodownik C, Kaptsan A, Cohen H, Matar M, Loewenthal U, Kotler M.
    Am J Psychiatry; 2001 Sep; 158(9):1511-4. PubMed ID: 11532741
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effectiveness of melatonin in tardive dyskinesia.
    Castro F, Carrizo E, Prieto de Rincón D, Rincón CA, Asián T, Medina-Leendertz S, Bonilla E.
    Invest Clin; 2011 Sep; 52(3):252-60. PubMed ID: 21950196
    [Abstract] [Full Text] [Related]

  • 14. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B, Mester R, Abesgaus J, Wittenberg N, Adlersberg S, Gonen N, Weizman A.
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol.
    Beasley CM, Dellva MA, Tamura RN, Morgenstern H, Glazer WM, Ferguson K, Tollefson GD.
    Br J Psychiatry; 1999 Jan; 174():23-30. PubMed ID: 10211147
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Tardive dyskinesia: pergolid, a possible therapeutic option].
    Diehl A, Braus DF, Büchel C, Krumm B, Medori R, Gattaz WF.
    Psychiatr Prax; 2003 Sep; 30(6):333-7. PubMed ID: 12970819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.